Plus Therapeutics Inc (PSTV) – Don’t Be So Quick to Call it Dead

Plus Therapeutics Inc (NASDAQ: PSTV) is -50.99% lower on its value in year-to-date trading and has touched a low of $0.24 and a high of $2.67 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PSTV stock was last observed hovering at around $0.50 in the last trading session, with the day’s gains setting it 0.06%.

Currently trading at $0.56, the stock is -21.47% and -34.71% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.21 million and changing 12.74% at the moment leaves the stock -54.16% off its SMA200. PSTV registered -68.69% loss for a year compared to 6-month loss of -58.25%.

The stock witnessed a -31.93% gain in the last 1 month and extending the period to 3 months gives it a -55.97%, and is -21.65% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.82% over the week and 16.95% over the month.

Plus Therapeutics Inc (PSTV) has around 21 employees, a market worth around $9.58M and $5.82M in sales. Profit margin for the company is -222.84%. Distance from 52-week low is 134.83% and -78.89% from its 52-week high.

The EPS is expected to grow by 57.69% this year

The shares outstanding are 17.00M, and float is at 16.57M with Short Float at 6.81%.

Plus Therapeutics Inc (PSTV) Insider Activity

Plus Therapeutics Inc disclosed in a document filed with the SEC on Sep 13 ’24 that Hawkins Richard J (Director) bought a total of 4,000 shares of the company’s common stock. The trade occurred on Sep 13 ’24 and was made at $1.50 per share for $5996.0. Following the transaction, the insider now directly holds 15188.0 shares of the PSTV stock.

Still, SEC filings show that on Sep 12 ’24, Hawkins Richard J (Director) acquired 6,285 shares at an average price of $1.35 for $8512.0. The insider now directly holds 11,188 shares of Plus Therapeutics Inc (PSTV).

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.